Antiviral Efficacy and Host Innate Immunity Associated with SB 9200 Treatment in the Woodchuck Model of Chronic Hepatitis B von Korolowicz, Kyle E, Iyer, Radhakrishnan P, Czerwinski, Stefanie, Suresh, Manasa, Yang, Junming, Padmanabhan, Seetharamaiyer, Sheri, Anjaneyulu, Pandey, Rajendra K, Skell, Jeffrey, Marquis, Judith K, Kallakury, Bhaskar V, Tucker, Robin D, Menne, Stephan

Volltext

Antiviral Efficacy and Host Immune Response Induction during Sequential Treatment with SB 9200 Followed by Entecavir in Woodchucks von Suresh, Manasa, Korolowicz, Kyle E, Balarezo, Maria, Iyer, Radhakrishnan P, Padmanabhan, Seetharamaiyer, Cleary, Dillon, Gimi, Rayomand, Sheri, Anjaneyulu, Yon, Changsuek, Kallakury, Bhaskar V, Tucker, Robin D, Afdhal, Nezam, Menne, Stephan

Volltext

NOD2/RIG-I Activating Inarigivir Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in Mice von Khan, Arshad, Singh, Vipul K, Mishra, Abhishek, Soudani, Emily, Bakhru, Pearl, Singh, Christopher R, Zhang, Dekai, Canaday, David H, Sheri, Anjaneyulu, Padmanabhan, Seetharamaiyer, Challa, Sreerupa, Iyer, Radhakrishnan P, Jagannath, Chinnaswamy

Volltext

SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variants von Jones, Meleri, Cunningham, Morven E., Wing, Peter, DeSilva, Sampath, Challa, Rupa, Sheri, Anjaneyulu, Padmanabhan, Seetharamaiyer, Iyer, Radhakrishnan P., Korba, Brent E., Afdhal, Nezam, Foster, Graham R.

Volltext

Penicillin Sulfone Inhibitors of Class D β-Lactamases von DRAWZ, Sarah M, BETHEL, Christopher R, BONOMO, Robert A, DOPPALAPUDI, Venkata R, SHERI, Anjaneyulu, SUNDAR RAM REDDY PAGADALA, HUJER, Andrea M, SKALWEIT, Marion J, ANDERSON, Vernon E, CHEN, Shu G, BUYNAK, John D

Volltext

Structures of SHV-1 β-lactamase with penem and penam sulfone inhibitors that form cyclic intermediates stabilized by carbonyl conjugation von Ke, Wei, Pattanaik, Priyaranjan, Bethel, Christopher R, Sheri, Anjaneyulu, Buynak, John D, Bonomo, Robert A, van den Akker, Focco

Volltext

Preclinical studies of SB 11285, a novel STING agonist for immuno-oncology von Challa, Sreerupa Valli, Zhou, Shenghua, Sheri, Anjaneyulu, Padmanabhan, Seetharamaiyer, Meher, Geeta, Gimi, Rayomand, Schmidt, Diane, Cleary, Dillon, Afdhal, Nezam, Iyer, Radhakrishnan

Volltext

Abstract B87: Mechanistic insights into the antitumor activity of SB 11285—a novel STING agonist von Zhou, Shenghua, Challa, Sreerupa, Nair, Vishal, Meher, Geeta, Sheri, Anjaneyulu, Gimi, Rayomand, Padmanabhan, Seetharamaiyer, Cleary, Dillon, Suppiah, Leena, Schmidt, Diane, Khedkar, Santosh, Iyer, Radhakrishnan

Volltext

Abstract B75: Nanoparticle formulation of the STING agonist SB 11285 von Challa, Sreerupa, Suppiah, Leena, Cleary, Dillon, Sheri, Anjaneyulu, Gimi, Rayomand, Meher, Geeta, Padmanabhan, Seetharamaiyer, Shah, Sumit, Bhatt, Pranav, Tauro, Jovita, Iyer, Radhakrishnan

Volltext

Abstract B53: Development of SB 11 and SB 12, structurally unique linkage analogs of SB 11285 as STING agonists for Immuno-oncology von Zhou, Shenghua, Challa, Sreerupa, Shmidt, Diane, Suppiah, Leena, Nair, Vishal, Sheri, Anjaneyulu, Meher, Geeta, Gimi, Rayomand, Padmanabhan, Seetharamaiyer, Cleary, Dillon, Iyer, Radhakrishnan

Volltext

Novel small molecule nucleotide homologs (SMNH) activate human macrophages to kill intracellular Mycobacterium tuberculosis . (VAC6P.949) von Khan, Arshad, Singh, Christopher, Pandey, Rajendra, Sheri, Anjaneyulu, Padmanabhan, Seetharamaiyer, Iyer, Radhakrishan, Jagannath, Chinnaswamy

Volltext

Abstract B39: Novel dinucleotides that activate STING signaling for immuno-oncology von Zhou, Shenghua, Challa, Sreerupa, Padmanabhan, Seetharamaiyer, Sheri, Anjaneyulu, Delaney, Samantha, Meher, Geeta, Cleary, Dillon, Gimi, Rayomand, Khedkar, Santosh, Iyer, Radhakrishnan

Volltext

Abstract B40: Nucleotide analogs as novel STING agonists for immuno-oncology von Challa, Sreerupa, Zhou, Shenghua, Sheri, Anjaneyulu, Padmanabhan, Seetharamaiyer, Delaney, Samantha, Meher, Geeta, Cleary, Dillon, Nair, Vishal, Gimi, Rayomand, Khedkar, Santosh, Iyer, Radhakrishnan

Volltext

Use of Raman Spectroscopy to Characterize Hydrogenation Reactions von Tumuluri, Venkat S, Kemper, Mark S, Sheri, Anjaneyulu, Choi, Seoung-Ryoung, Lewis, Ian R, Avery, Mitchell A, Avery, Bonnie A

Volltext

Structures of SHV-1 [beta]-Lactamase with Penem and Penam Sulfone Inhibitors That Form Cyclic Intermediates Stabilized by Carbonyl Conjugation von Ke, Wei, Pattanaik, Priyaranjan, Bethel, Christopher R, Sheri, Anjaneyulu, Buynak, John D, Bonomo, Robert A, van den Akker, Focco

Volltext

The synthesis and biological evaluation of 2-(3-methyl or 3-phenylisoxazol-5-yl)-3-aryl-8-thiabicyclo[3.2.1]octanes von Purushotham, Madhusudhan, Sheri, Anjaneyulu, Pham-Huu, Duy-Phong, Madras, Bertha K., Janowsky, Aaron, Meltzer, Peter C.

Volltext

Efficient Inhibition of Class A and Class D β-Lactamases by Michaelis Complexes von Kalp, Matthew, Sheri, Anjaneyulu, Buynak, John D., Bethel, Christopher R., Bonomo, Robert A., Carey, Paul R.

Volltext

Penicillin Sulfone Inhibitors of Class D ?-Lactamases von Drawz, Sarah M, Bethel, Christopher R, Doppalapudi, Venkata R, Sheri, Anjaneyulu, Reddy Pagadala, Sundar Ram, Hujer, Andrea M, Skalweit, Marion J, Anderson, Vernon E, Chen, Shu G, Buynak, John D, Bonomo, Robert A

Volltext

Why Clinically Used Tazobactam and Sulbactam Are Poor Inhibitors of OXA-10 β-Lactamase: Raman Crystallographic Evidence von Totir, Monica A, Cha, Jooyoung, Ishiwata, Akihiro, Wang, Benlian, Sheri, Anjaneyulu, Anderson, Vernon E, Buynak, John, Mobashery, Shahriar, Carey, Paul R

Volltext

The Importance of the trans-Enamine Intermediate as a [beta]-Lactamase Inhibition Strategy Probed in Inhibitor-Resistant SHV [beta]-Lactamase Variants von Ke, Wei, Rodkey, Elizabeth A, Sampson, Jared M, Skalweit, Marion J, Sheri, Anjaneyulu, Pagadala, Sundar Ram Reddy, Nottingham, Michael D, Buynak, John D, Bonomo, Robert A, vandenAkker, Focco

Volltext